Business Wire

C5: Prestigious Team of Judges Announced for the Second Annual Shield in the Cloud Global Anti-Corruption Innovation Challenge

Jaa

C5, the specialist investment firm focused on cyber security, cloud computing, and artificial intelligence, today announced the judges for its Shield in the Cloud innovation challenge.

Shield in the Cloud is an annual global innovation challenge to attract the best and brightest minds working to innovate the fight against corruption with Amazon Web Services (AWS), PeaceTech Lab, and SAP NS2.

This year’s challenge will have a panel of five judges, an experienced group of legal, business and industry experts with expertise in national security, anti-corruption and innovation. They are:

  • Lucinda Low, Partner, Steptoe & Johnson LLP

In her practice, Lucinda Low has particular authority in matters involving the US Foreign Corrupt Practices Act (FCPA) and other anti-bribery and anti-corruption laws, as well as other international business compliance issues. Lucinda helps clients develop and implement customized compliance programs tailored to their business risks that meet regulatory expectations, assists with due diligence in M&A and other transactions, provides risk-mitigation and risk assessment strategy, conducts internal investigations, and defends clients in government investigation and enforcement matters, including multijurisdictional investigations.

  • Kurt Scherer, Chief of Staff, C5 Washington DC
    Kurt joined C5 in September as part of the firm’s leadership. He also served as the Director of Booz Allen’s DC Innovation Center and its national innovation hub network. He leads a network of Booz Allen teams, alliance partners, entrepreneurs, and other members of a broad innovation ecosystem to increase the flow of the right ideas, talent, and technologies to solve complex mission and business problems.
  • Jay Collins, Vice Chairman Corporate and Investment Banking, Citi

Jay is Vice Chairman of Corporate and Investment Banking and Citi’s senior government banker. He is responsible for driving content, innovation and replicable solutions across Citi’s sovereign, supranational and local government client base. During his career, Jay has advised over 50 governments on privatizations, liability management and funding strategies, derivatives, and electronic banking services, including a wide range of digital solutions. Jay is also an Adjunct Professor at Georgetown University.

  • Moira Andrews, Director, Praetor Legal Limited

Moira is a lawyer with over thirty years’ experience. Moira served in the British government at the Legal Counsel in a national security agency. She is an expert in national security, governance and leadership, international security and justice.

  • Andre Pienaar, Founder, C5
    Andre is a lawyer and expert on cyber law. He is the founder of C5, a specialist venture capitalist group focused on cybersecurity, artificial intelligence, and the cloud. Andre serves on the board of directors for Omada, the Haven Group, and IronNet Cybersecurity. Andre is also a member of the United States Institute of Peace (USIP)’s International Advisory Council and the PeaceTech Lab board.

Entries to Shield in the Cloud are now open, and close on the 31st December 2018. There are three award categories:

  • Dream Big Shield. This is the prize for the most innovative start up that uses cloud to enable anti-corruption compliance, or the most innovative technology company with the best application or platform on cloud that enables anti-corruption compliance
  • Government Shield. This is the prize for the government department or multilateral organization with the best programme to drive innovation in anti-corruption using cloud.
  • NFP Shield. This is the prize for the NFP that uses cloud in the most innovative way to do anti-corruption work.

The judges will be looking for the most innovative startups, non-profits and governments innovating uses of technology for anti-corruption compliance worldwide. The winners will be announced at a gala dinner in Washington D.C. on 19 March 2019.

The prize includes AWS cloud credits and the opportunity to join the Peacetech Accelerator in Washington D.C., where they will further develop their products under the guidance of C5, AWS, SAP NS2 and PeaceTech Lab mentors. As part of this eight-week accelerator program, they will be supported by a highly experienced group of prominent international technology entrepreneurs, business leaders, investors and peace innovators. Best-in-class technical training is delivered by AWS solutions architects.

Companies can enter the challenge by emailing zach.beecher@clc.uk.com.

--ENDS--

About C5

C5 is a global venture capital firm investing in Secure Data Ecosystems, cyber security, cloud computing, data analytics and artificial intelligence. C5 has offices in Washington, London, Munich, Luxembourg and Bahrain.

C5 Accelerate with AWS, SAP NS2, and the PeaceTech Lab operates a PeaceTech accelerator in Washington, DC that scale up start-ups to prevent, predict, and mitigate conflict to make peace sustainable. The PeaceTech Accelerator is building a network of 1500 entrepreneurs worldwide dedicated to the mission to innovate peacebuilding and security.

About Shield in the Cloud

The Shield in the Cloud innovation challenge is aligned with Goal 16 of the United Nations’ Global Sustainable Goal to promote just, peaceful and inclusive societies. This Goal seeks to hold institutions and governments accountable and transparent. It also aims to eliminate bribery and other forms of political and corporate corruption.

For more information on Shield in the Cloud, please visit:

www.c5accelerate.com/shieldinthecloud

Twitter: @c5accelerate

Instagram: c5.accelerate

Contact information

C5
John Merva
or
Emily Jones
or
Sheena Munsami
C5Capital@hudsonsandler.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Vertex Announces European Commission Approval for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease21.1.2019 12:00Tiedote

Vertex Pharmaceuticals (Europe) Limited today announced that the European Commission has granted approval of the label extension for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of children with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease. “Today’s approval by the European Commission brings us one step closer to our goal of bringing treatment to all people living with CF,” said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. ‘‘By treating the underlying cause of disease early, we can potentially modify its course and offer patients the chance of improved outcomes.’’ The label update is based on data from a Phase 3 open-label safety study in 60 patients that showed treatment with lumacaftor/ivacaftor was generally well tolerated for 24 weeks, with a safety profile in these pediatric patients generally consistent with

Anticipation Builds as MWC19 Barcelona Approaches21.1.2019 12:00Tiedote

The GSMA today announced final updates for MWC19 Barcelona (formerly Mobile World Congress), including additional keynote speakers, participating companies, programmes and events. Taking place 25-28 February 2019, with events being staged at Fira Gran Via, Fira Montjuïc and La Farga L’Hospitalet, MWC19 Barcelona is set to attract more than 107,000 professionals from over 200 countries and territories. “With the anticipated arrival of 5G, this year’s event is set to be one of the most exciting as the industry convenes to showcase Intelligent Connectivity across new technologies on the brink of reaching millions of people across the world,” said John Hoffman, CEO, GSMA Ltd. “Over the four days of MWC19, attendees will have the opportunity to hear from leaders who are driving innovation and we look forward once again to welcoming the mobile world to Barcelona.” Global Leaders to Keynote The GSMA announced the addition of several new keynote speakers for MWC19 including executives from lea

B2C2 Launches Streaming OTC Pricing with Point-and-Click Execution21.1.2019 12:00Tiedote

B2C2, one of the largest cryptocurrency liquidity providers and the leader in electronic OTC trading, today announced the launch of streaming pricing with point-and-click execution on its OTC platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005063/en/ Max Boonen, Founder and CEO of B2C2 (Photo: Business Wire) For the first time, B2C2’s clients will be able to view and execute trades on a real-time two-way market, via the firm’s secure web interface. The new functionality allows market participants to easily monitor live pricing in user-defined quantities and execute with the click of a button, as they would on traditional FX trading platforms. The launch rounds out a number of milestones for B2C2 in 2018, including surpassing 2017 peak volumes; rolling out a completely redesigned front-end; forming integration partnerships with the major liquidity hubs; and launching a research offering. Founded in 2015, B2C2 i

Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize RNAi Therapeutics in Israel21.1.2019 11:00Tiedote

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma, Israel’s leading commercial partner for innovative pharmaceuticals, announced today an exclusive agreement to commercialize ONPATTRO®, the first-ever commercialized RNAi therapeutic, as well as other investigational therapeutics under development in the Alnylam RNAi portfolio. “Our partnership with Medison marks an important step in our global commercial expansion and signals our intent to ensure that patients suffering from serious rare diseases have access to our medicines, regardless of location,” said Theresa Heggie, SVP and Head of Europe, Middle East and Africa, and Canada, Alnylam Pharmaceuticals. “Medison has a strong organization with a proven track record of commercializing orphan products successfully, together with an infrastructure uniquely suited to supporting patients suffering from rare diseases in Israel and providing access to our potentially transformational thera

Gore Introduces GORE® TAG® Conformable Thoracic Stent Graft with Reduced Profiles in Europe21.1.2019 11:00Tiedote

W. L. Gore & Associates, Inc. (Gore) today introduced reduced profiles for the most commonly used diameters of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System. The reduced profile allows physicians to perform TEVAR in patients with smaller vessels where access is challenging and aortic anatomy is tortuous, expanding the availability of Gore’s thoracic stent graft to a greater population of patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005042/en/ GORE(R) TAG(R) Conformable Thoracic Stent Graft with ACTIVE CONTROL System (Photo: Business Wire) The GORE® TAG® Conformable Thoracic Stent Graft was modified to reduce the delivery profile of the 31, 37, and 40 mm device diameters by 2 Fr for all lengths. The reduction in profile, through the use of a smaller diameter primary sleeve, is the only change to the device. The stent graft leverages the same predictable outcomes of the time-teste

HCL 2030 Ecosystem Platform to Explore Societal Implications of Emerging Technology at the World Economic Forum21.1.2019 10:26Tiedote

HCL Technologies (HCL), a leading global technology company and the World Economic Forum’s Strategic Partner, today announced its largest presence to date at the side-lines of World Economic Forum’s Annual Meeting in Davos scheduled from 21st January 2019 to 25th January 2019. The company will host a three-day event in a special Pavilion that will feature a technology showcase, thought-leadership programs, as well as a number of high-level networking and social events throughout the tenure of the conference. The overarching theme of the HCL and Fast Company programs will explore how humanity’s relationship with technology will evolve through the next decade of rapid innovation. HCL has partnered with Fast Company to develop a thought-leadership track that includes three panel discussion breakfasts. As part of the theme of Human-Machine Harmony, HCL is launching the HCL 2030 Platform, together with its ecosystem of partners and stakeholders, that will conduct in-depth explorations and d

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme